Publication | Closed Access

The clinical impact of interferon beta antibodies in relapsing-remitting MS

Clinical ImmunologyInterferon Beta AntibodiesAutoimmune DiseaseImmunodeficienciesImmunologyAutoimmunityImmunologic DiseaseImmunosuppressionMultiple SclerosisImmunotherapyMedicineCell Transplantation